Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhaowei Hua

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Statistics in Biosciences|June 19, 2015
Semiparametric Bayes local additive models for longitudinal dataZhaowei Hua, Hongtu Zhu, David B Dunson
Journal of Biopharmaceutical Statistics|July 11, 2019
<i>Z</i><sub>max</sub> test for delayed effect in immuno-oncology clinical trialsMiao Yang, Zhaowei Hua, Lan Xue, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2004
Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cellsWenjing Li, Lingfei Hou, Zhaowei Hua, et al.
Neuroimage|June 27, 2012
Semiparametric Bayesian local functional models for diffusion tensor tract statisticsZhaowei Hua, David B Dunson, John H Gilmore, et al.
Clinical and Translational Science|November 24, 2017
Model-Based Meta-Analysis for Multiple Myeloma: A Quantitative Drug-Independent Framework for Efficient Decisions in Oncology Drug DevelopmentZhaoyang Teng, Neeraj Gupta, Zhaowei Hua, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2024
Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy studyBin Fan, Ghassan K Abou-Alfa, Andrew X Zhu, et al.
Clinical and Translational Science|January 27, 2021
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trialXiaofei Zhou, Sharon Friedlander, Erik Kupperman, et al.
British Journal of Haematology|March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 studyRonan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Journal of Alzheimer'S Disease : JAD|September 30, 2011
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adultsLilian Calderón-Garcidueñas, Michael Kavanaugh, Michelle Block, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or LymphomaJatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Statistics in Biosciences|June 19, 2015
Semiparametric Bayes local additive models for longitudinal dataZhaowei Hua, Hongtu Zhu, David B Dunson
Journal of Biopharmaceutical Statistics|July 11, 2019
<i>Z</i><sub>max</sub> test for delayed effect in immuno-oncology clinical trialsMiao Yang, Zhaowei Hua, Lan Xue, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 21, 2004
Interleukin-1beta induces beta-calcitonin gene-related peptide secretion in human type II alveolar epithelial cellsWenjing Li, Lingfei Hou, Zhaowei Hua, et al.
Neuroimage|June 27, 2012
Semiparametric Bayesian local functional models for diffusion tensor tract statisticsZhaowei Hua, David B Dunson, John H Gilmore, et al.
Clinical and Translational Science|November 24, 2017
Model-Based Meta-Analysis for Multiple Myeloma: A Quantitative Drug-Independent Framework for Efficient Decisions in Oncology Drug DevelopmentZhaoyang Teng, Neeraj Gupta, Zhaowei Hua, et al.
Cancer Chemotherapy and Pharmacology|January 26, 2024
Pharmacokinetics/pharmacodynamics of ivosidenib in advanced IDH1-mutant cholangiocarcinoma: findings from the phase III ClarIDHy studyBin Fan, Ghassan K Abou-Alfa, Andrew X Zhu, et al.
Clinical and Translational Science|January 27, 2021
Asia-inclusive global development of pevonedistat: Clinical pharmacology and translational research enabling a phase 3 multiregional clinical trialXiaofei Zhou, Sharon Friedlander, Erik Kupperman, et al.
British Journal of Haematology|March 4, 2015
Pevonedistat (MLN4924), a First-in-Class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukaemia and myelodysplastic syndromes: a phase 1 studyRonan T Swords, Harry P Erba, Daniel J DeAngelo, et al.
Journal of Alzheimer'S Disease : JAD|September 30, 2011
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adultsLilian Calderón-Garcidueñas, Michael Kavanaugh, Michelle Block, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2015
Phase I Study of the Novel Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (MLN4924) in Patients with Relapsed/Refractory Multiple Myeloma or LymphomaJatin J Shah, Andrzej J Jakubowiak, Owen A O'Connor, et al.
Pageof 2